FDA releases Biosimilar Action Plan
Hurdles to adoption of biosimilars include regulatory issues and lack of interchangeability with the reference drugs.
Pharmacists are drug specialists. If their duty is to use their knowledge in service to patients, can they be sued for speaking up?
The answer, it turns out, is "Plenty." Just ask Topeka Pharmacy's Tom and Morag Miller.
CPF puts its money where its mission is.